Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
JAMA Neurol. 2021 May 1;78(5):558-567. doi: 10.1001/jamaneurol.2021.0405.
JAMA Neurol. 2021.
PMID: 33779698
Free PMC article.
Clinical Trial.
Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies.
Freedman MS, Pozzilli C, Havrdova EK, Lemle A, Burcklen M, Larbalestier A, Hennessy B, Sidorenko T, Vaclavkova A, Olsson T; Ponesimod Phase II Study Group.
Freedman MS, et al. Among authors: vaclavkova a.
Neurology. 2022 Aug 23;99(8):e762-e774. doi: 10.1212/WNL.0000000000200606. Epub 2022 Jun 6.
Neurology. 2022.
PMID: 35667837
Free PMC article.
Clinical Trial.
Item in Clipboard
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial.
Vaclavkova A, Chimenti S, Arenberger P, Holló P, Sator PG, Burcklen M, Stefani M, D'Ambrosio D.
Vaclavkova A, et al.
Lancet. 2014 Dec 6;384(9959):2036-45. doi: 10.1016/S0140-6736(14)60803-5. Epub 2014 Aug 10.
Lancet. 2014.
PMID: 25127208
Clinical Trial.
Item in Clipboard
Mitigation of Initial Cardiodynamic Effects of the S1P1 Receptor Modulator Ponesimod Using a Novel Up-Titration Regimen.
Juif PE, Hoch M, Vaclavkova A, Krause A, Bush J, Dingemanse J.
Juif PE, et al. Among authors: vaclavkova a.
J Clin Pharmacol. 2017 Mar;57(3):401-410. doi: 10.1002/jcph.820. Epub 2016 Sep 30.
J Clin Pharmacol. 2017.
PMID: 27558098
Clinical Trial.
Item in Clipboard
Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P₁ Receptor Modulator in Healthy Subjects.
Juif PE, Baldoni D, Reyes M, Wilbraham D, Febbraro S, Vaclavkova A, Hoch M, Dingemanse J.
Juif PE, et al. Among authors: vaclavkova a.
Int J Mol Sci. 2017 Dec 6;18(12):2636. doi: 10.3390/ijms18122636.
Int J Mol Sci. 2017.
PMID: 29211013
Free PMC article.
Clinical Trial.
Item in Clipboard
Pharmacokinetic-Pharmacodynamic Modeling of the Ponesimod Effect on Heart Rate in Patients With Multiple Sclerosis.
Valenzuela B, Poggesi I, Luyckx N, Vaclavkova A, Pérez-Ruixo JJ.
Valenzuela B, et al. Among authors: vaclavkova a.
Clin Pharmacol Ther. 2023 Mar;113(3):692-703. doi: 10.1002/cpt.2827. Epub 2023 Jan 30.
Clin Pharmacol Ther. 2023.
PMID: 36524329
Item in Clipboard
Cite
Cite